Keryx Biopharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsKeryx Biopharmaceuticals

Keryx Biopharmaceuticals(KERX)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Auryxia	Ferric pyrophosphate citrate	2014-09-05		—

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

diabetic nephropathies

,

kidney diseases

,

,

,

essential hypertension

,

,

left ventricular hypertrophy

,

,

systolic murmurs

,

isolated systolic hypertension

,

diabetes mellitus

ankylosing spondylitis

,

rheumatoid arthritis

,

,

spondylarthritis

,

myelodysplastic syndromes

,

myelodysplastic-myeloproliferative diseases

,

ovarian neoplasms

,

fallopian tube neoplasms

,

,

myeloid leukemia acute

,

promyelocytic leukemia acute

,

congenital abnormalities

,

precursor cell lymphoblastic leukemia-lymphoma

,

biphenotypic leukemia acute

,

bcr-abl positive chronic myelogenous leukemia

,

megakaryoblastic leukemia acute

,

monocytic leukemia acute

,

myelomonocytic leukemia acute

,

myeloid leukemia chronic-phase

,

myeloid leukemia

,

myeloid leukemia accelerated phase

,

erythroblastic leukemia acute

,

,

myeloproliferative disorders

,

,

,

,

,

kidney neoplasms

,

brain neoplasms

,

,

renal cell carcinoma

,

,

,

colonic neoplasms

,

gastrointestinal stromal tumors

,

,

,

oligodendroglioma

,

breast neoplasms

,

non-small-cell lung carcinoma

,

waldenstrom macroglobulinemia

,

prostatic neoplasms

,

pancreatic neoplasms

,

,

,

,

alveolar soft part sarcoma

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

,

head and neck neoplasms

,

endometrial neoplasms

,

,

multiple myeloma

,

plasma cell neoplasms

,

colorectal neoplasms

,

,

,

acquired immunodeficiency syndrome

,

communicable diseases

,

hepatic insufficiency

,

healthy volunteers/patients

,

ischemic stroke

chronic kidney failure

,

kidney diseases

breast neoplasms

,

,

endometrial neoplasms

,

stomach neoplasms

,

myeloproliferative disorders

,

,

multiple myeloma

,

cholangiocarcinoma

,

non-small-cell lung carcinoma

,

fallopian tube diseases

,

,

stomach neoplasms

,

,

squamous cell carcinoma

,

,

ovarian neoplasms

,

neoplasm metastasis

,

urologic neoplasms

,

fallopian tube neoplasms

,

squamous cell neoplasms

,

renal cell carcinoma

,

colorectal neoplasms

,

transitional cell carcinoma

,

uterine cervical neoplasms

,

castration-resistant prostatic neoplasms

,

small cell lung carcinoma

,

,

,

ovarian epithelial carcinoma

,

endometrial neoplasms

,

female genital neoplasms

,

hypersensitivity

,

adenocarcinoma of lung

,

urinary bladder neoplasms

,

peritoneal neoplasms

,

neuroendocrine carcinoma

,

chemoradiotherapy

,

,

non-small-cell lung carcinoma

,

breast neoplasms

,

,

prostatic neoplasms

,

squamous cell carcinoma of head and neck

,

head and neck neoplasms

,

esophageal neoplasms

,

pancreatic neoplasms

,

,

triple negative breast neoplasms

,

pancreatic ductal carcinoma

,

esophageal squamous cell carcinoma

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use